This is a "connection" page, showing publications co-authored by Thomas N. Krausz and Carrie A. Fitzpatrick.
BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma. Hum Pathol. 2017 02; 60:86-94.
MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma. Mod Pathol. 2020 02; 33(2):245-254.
Disseminated Malignant Rhabdoid Tumor of the Head and Neck. Head Neck Pathol. 2017 Jun; 11(2):224-227.